The halt will remain in place until that start of normal trading on the ASX on Monday, July 22, or when an announcement is released to the market, whichever occurs earliest.
ShareRoot securities last traded at 0.2 cents.
The company this week raised more than $509,600 from eligible shareholders in a non-renounceable pro-rata entitlement offer.
At the time the company said that it was in discussions with a number of parties and brokers in relation to shortfall shares.
Funds from the entitlement offer will provide capital for the company to drive towards near-term profitability.
ShareRoot recently completed a restructure and has a clear path forward to a successful business in the digital healthcare industry.
The company is looking to leverage momentum in compliantly accessing real world data and real-world evidence in healthcare, by using artificial intelligence, machine learning and a proprietary analysis process to gain deeper insights.
This will enable the delivery of better healthcare and more patient-centric development of new medicines, medical devices and clinical practice.